Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/09/639
Active ingredient: 4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo[b,e][1,4]diazepin-11-one
Indication: Treatment of glioma
Sponsor: Albany Regulatory Consulting Limited
Sumpter House, 8 Station Road, Histon, Cambridge CB4 9LQ, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Centralised Orphan - Designation EMEA/OD/004/09 (2009)4059 of 15/05/2009
16/07/2012 Centralised Orphan - Removal of orphan designation from Community Register